Bioceres Crop Solutions Corp (BIOX) FinancialsBIOXBioceres Crop Solutions Corp

Bioceres Crop Solutions Corp (BIOX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Crop protection, accounting for 56.8% of total sales, equivalent to $42.35M. Other significant revenue streams include Crop nutrituion and Seed and integrated products. Understanding this composition is critical for investors evaluating how BIOX navigates market cycles within the Agricultural Chemicals industry.

Evaluating the bottom line, Bioceres Crop Solutions Corp maintains a gross margin of 30.10%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -14.40%, while the net margin is -26.44%. These profitability ratios, combined with a Return on Equity (ROE) of -41.96%, provide a clear picture of how effectively BIOX converts its operational activities into shareholder value.

In the context of the broader market, BIOX competes directly with industry leaders such as SNES and RKDA. With a market capitalization of $28.65M, it holds a leading position in the sector. When comparing efficiency, BIOX's gross margin of 30.10% stands against SNES's 73.64% and RKDA's 36.36%. Such benchmarking helps identify whether Bioceres Crop Solutions Corp is trading at a premium or discount relative to its financial performance.

Bioceres has reported a total revenue decline of 23% year-over-year, with a significant gross profit drop of 30%. The company has also shown negative net income figures, including a net income of -$18,303,921 in Q2 2026, indicating ongoing financial struggles.